A team of Connecticut biotech veterans is turning the proceeds of a $1.3 billion acquisition into a platform for the next generation of life sciences startups.
GLP-1 drugs have reshaped the obesity-treatment market and cut into bariatric surgery volumes — but Connecticut's major health systems say the two approaches work better together than apart.
A New Haven investment firm sees opportunity in one of Waterbury's most troubled properties — and city officials are betting private money can do what crackdowns alone couldn't.
Gov. Ned Lamont is campaigning on fixing healthcare costs and electric bills — two problems that have persisted throughout his nearly eight years in office.
Two Connecticut credit unions are switching charters — in opposite directions — as they race to grow beyond their traditional markets in an increasingly digital and competitive banking landscape.
An entrepreneur built Connecticut's first billion-dollar tech company — then left to build a competitor. Now the company he started is suing him over patents and employee agreements.
A federal hearing on marijuana rescheduling has set the industry buzzing, but Connecticut cannabis operators say the path forward is anything but clear.